Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Antibody-drug conjugates as novel anti-cancer chemotherapeutics.

Peters C, Brown S.

Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089. Review.

2.

Current ADC Linker Chemistry.

Jain N, Smith SW, Ghone S, Tomczuk B.

Pharm Res. 2015 Nov;32(11):3526-40. doi: 10.1007/s11095-015-1657-7. Epub 2015 Mar 11. Review.

3.

After Venus, mercury: syphilis treatment in the UK before Salvarsan.

Gelpi A, Tucker JD.

Sex Transm Infect. 2015 Feb;91(1):68. doi: 10.1136/sextrans-2014-051778. No abstract available.

4.

An Overview of Arsenic Metabolism and Toxicity.

Drobna Z, Styblo M, Thomas DJ.

Curr Protoc Toxicol. 2009;42(431):4.31.1-4.31.6.

5.

Melanoma vaccines: mixed past, promising future.

Ozao-Choy J, Lee DJ, Faries MB.

Surg Clin North Am. 2014 Oct;94(5):1017-30, viii. doi: 10.1016/j.suc.2014.07.005. Epub 2014 Aug 7. Review.

6.

Site-specific antibody drug conjugates for cancer therapy.

Panowski S, Bhakta S, Raab H, Polakis P, Junutula JR.

MAbs. 2014 Jan-Feb;6(1):34-45. doi: 10.4161/mabs.27022. Review.

7.

Reporter phage and breath tests: emerging phenotypic assays for diagnosing active tuberculosis, antibiotic resistance, and treatment efficacy.

Jain P, Thaler DS, Maiga M, Timmins GS, Bishai WR, Hatfull GF, Larsen MH, Jacobs WR.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1142-50. doi: 10.1093/infdis/jir454. Review.

8.
9.

The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.

Bosch F, Rosich L.

Pharmacology. 2008;82(3):171-9. doi: 10.1159/000149583. Epub 2008 Aug 5. Review.

10.

Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity.

Du X, Beers R, Fitzgerald DJ, Pastan I.

Cancer Res. 2008 Aug 1;68(15):6300-5. doi: 10.1158/0008-5472.CAN-08-0461.

11.

Cancer pharmacotherapy: 21st century 'magic bullets' and changing paradigms.

Lewis LD.

Br J Clin Pharmacol. 2006 Jul;62(1):1-4. No abstract available.

12.

Structure-guided design of a novel class of benzyl-sulfonate inhibitors for influenza virus neuraminidase.

Platis D, Smith BJ, Huyton T, Labrou NE.

Biochem J. 2006 Oct 15;399(2):215-23.

Items per page

Supplemental Content

Write to the Help Desk